Evidence map›Paper›PMID 39817711›Full record

ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2025

Use of nicotine vaping products during an attempt to quit smoking by Canadian adults who smoke or recently quit: findings from the 2022 Canada International Tobacco Control Four Country Smoking and Vaping Survey.

Shannon Gravely, David Sweanor, Pete Driezen, David T Levy, Geoffrey T Fong, Anne C K Quah, Lorraine V Craig, Janet Chung-Hall, Susan C Kaai, K Michael Cummings

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shannon GravelyDepartment of Psychology, University of Waterloo, ON, Canada.
David SweanorFaculty of Law, University of Ottawa, ON, Canada.
Pete DriezenDepartment of Psychology, University of Waterloo, ON, Canada.
David T LevySchool of Medicine, Georgetown University, Washington, DC, USA.
Geoffrey T FongDepartment of Psychology, University of Waterloo, ON, Canada.
Anne C K QuahDepartment of Psychology, University of Waterloo, ON, Canada.
Lorraine V CraigDepartment of Psychology, University of Waterloo, ON, Canada.
Janet Chung-HallDepartment of Psychology, University of Waterloo, ON, Canada.
Susan C KaaiDepartment of Psychology, University of Waterloo, ON, Canada.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An analysis of 1771 Canadian adults who smoke or used to smoke cigarettes was conducted using data from the 2022 International Tobacco Control Four Country Smoking and Vaping Survey. Using weighted data, we estimated the prevalence of Canadian adults who tried to quit smoking between 2020 and 2022, and the use of a nicotine vaping product (NVP) and the flavours and devices used most often at their most recent quit attempt. Overall, 36.5% made a quit attempt; of those, 19.4% used an NVP. Those who were younger and quit smoking were more likely to have used an NVP. Prefilled cartridges or pods (36.3%) and fruit flavours (39.5%) were used most frequently.

Indexed as

Smoking CessationVapingAdolescentAdultCanadaElectronic Nicotine Delivery SystemsFemaleHumansMaleMiddle AgedPrevalenceTobacco ControlYoung Adultcigarette smokingnicotine vapingpolicyquit attemptvaping devicesvaping flavours

Identifiers

PMID39817711
PMCPMC11785162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.